A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

  • STATUS
    Not Recruiting
  • participants needed
    68
  • sponsor
    Fondazione Italiana Linfomi ONLUS
Updated on 4 August 2021
Investigator
Marina Cesaretti
Primary Contact
Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS - Ematologia (0.0 mi away) Contact
+31 other location

Summary

A phase II study to evaluate the combination of Lenalidomide and Rituximab as front line therapy for the treatment of elderly frail patients evaluated in CGA with Diffuse Large B-cells non-Hodgkin Lymphoma.

Description

This is a prospective, multicenter, single arm, phase II trial in elderly patients ( 70 years) affected by DLBCL defined as frail according to CGA and previously untreated.

The primary endpoint is to evaluate the efficacy of the R2 (Revlimid+Rituximab) combination in first line DLBCL patients not candidate for the standard R-CHOP (or R-CHOP like) treatments due to the frail status.

Details
Condition Diffuse Large B-cells Non-Hodgkin Lymphoma, Diffuse Large B-cells Non-Hodgkin Lymphoma, Diffuse Large B-cells Non-Hodgkin Lymphoma, Diffuse Large B-cells Non-Hodgkin Lymphoma
Treatment Rituximab-Dexamethasone-Lenalidomide
Clinical Study IdentifierNCT02955823
SponsorFondazione Italiana Linfomi ONLUS
Last Modified on4 August 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note